Cellectis S.A.
CLLS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001627281
No open-market purchases or sales by Cellectis S.A. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $28.4M in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in Cellectis S.A. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 50
- +5 vs. Q2 2022
- Shares held
- 10.3M
- −530.7K (−4.9%) vs. Q2 2022
- Total value
- $23.6M
- −$7.01M (−22.9%) vs. Q2 2022
- New holders
- 9
- 11 more added
- Sold out
- 4
- 16 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CLLS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 27 | $28.4M |
| Q1 2026 | 32 | $32.5M |
| Q4 2025 | 34 | $51.1M |
| Q3 2025 | 28 | $23.7M |
| Q2 2025 | 24 | $17.9M |
| Q1 2025 | 27 | $16.9M |
| Q4 2024 | 29 | $23.0M |
| Q3 2024 | 27 | $20.9M |
| Q2 2024 | 27 | $18.3M |
| Q1 2024 | 31 | $26.1M |
| Q4 2023 | 34 | $30.2M |
| Q3 2023 | 31 | $18.1M |
| Q2 2023 | 36 | $27.6M |
| Q1 2023 | 34 | $29.3M |
| Q4 2022 | 40 | $18.3M |
| Q3 2022 | 50 | $23.6M |
| Q2 2022 | 45 | $30.6M |
| Q1 2022 | 51 | $55.8M |
| Q4 2021 | 57 | $123.7M |
| Q3 2021 | 70 | $194.1M |
| Q2 2021 | 78 | $250.6M |
| Q1 2021 | 81 | $308.0M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Cellectis S.A.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| US Bancorp | 10 | $0 | 0.00% | 00.0% | Unchanged |
| FMR LLC | 9 | $0 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 56 | $0 | 0.00% | −52−48.1% | Reduced |
| Parkside Financial Bank & Trust | 147 | $0 | 0.00% | 00.0% | Unchanged |
| Daiwa Securities Group Inc. | 40 | $0 | 0.00% | 00.0% | Unchanged |
| China Universal Asset Management Co., Ltd. | 168 | $0 | 0.00% | +168 | New |
| TD Waterhouse Canada Inc. | 360 | $832 | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 253 | $1.00K | 0.00% | −71−21.9% | Reduced |
| Barclays PLC | 650 | $1.00K | 0.00% | +650 | New |
| JPMorgan Chase & Co | 1,350 | $3.00K | 0.00% | +407+43.2% | Added |
| Assetmark, Inc | 1,140 | $3.00K | 0.00% | +275+31.8% | Added |
| National Bank of Canada | 3,600 | $8.00K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 3,907 | $8.00K | 0.00% | +3,513+891.6% | Added |
| Advisor Group Holdings, Inc. | 6,403 | $15.0K | 0.00% | −400−5.9% | Reduced |
| Tower Research Capital LLC (TRC) | 7,062 | $16.0K | 0.00% | +699+11.0% | Added |
| Princeton Capital Management LLC | 10,594 | $24.0K | 0.01% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 10,776 | $24.0K | 0.00% | 00.0% | Unchanged |
| SEI Investments Co | 10,977 | $25.0K | 0.00% | +10,977 | New |
| Citadel Advisors LLC | 12,358 | $28.0K | 0.00% | −11,231−47.6% | Reduced |
| Two Sigma Investments, LP | 13,303 | $30.0K | 0.00% | +13,303 | New |
| Vontobel Holding Ltd. | 14,000 | $32.0K | 0.00% | 00.0% | Unchanged |
| Two Sigma Advisers, LP | 14,900 | $34.0K | 0.00% | −400−2.6% | Reduced |
| Wells Fargo & Company | 17,229 | $40.0K | 0.00% | +5,400+45.7% | Added |
| Balyasny Asset Management LLC | 18,352 | $42.0K | 0.00% | +18,352 | New |
| Bank of America Corp | 19,063 | $44.0K | 0.00% | −2,753−12.6% | Reduced |
| Baird Financial Group, Inc. | 32,640 | $74.0K | 0.00% | +32,640 | New |
| Envestnet Asset Management Inc | 45,519 | $104.0K | 0.00% | +24,580+117.4% | Added |
| WS Management LLLP | 50,907 | $117.0K | 0.02% | 00.0% | Unchanged |
| Hudson Bay Capital Management LP | 74,532 | $171.0K | 0.00% | −200,468−72.9% | Reduced |
| Morgan Stanley | 75,953 | $174.0K | 0.00% | −23,998−24.0% | Reduced |
| Vanguard Group Inc | 85,864 | $197.0K | 0.00% | +85,864 | New |
| Oppenheimer & Co Inc | 91,963 | $211.0K | 0.00% | +16,330+21.6% | Added |
| Kettle Hill Capital Management, LLC | 104,596 | $240.0K | 0.06% | +104,596 | New |
| Marshall Wace, LLP | 108,744 | $249.0K | 0.00% | −5,697−5.0% | Reduced |
| KBC Group NV | 163,447 | $374.0K | 0.00% | 00.0% | Unchanged |
| Woodline Partners LP | 169,802 | $389.0K | 0.01% | +169,802 | New |
| Mirae Asset Global Investments Co., Ltd. | 210,659 | $482.0K | 0.00% | +24,641+13.2% | Added |
| Macquarie Group Ltd | 226,875 | $520.0K | 0.00% | 00.0% | Unchanged |
| Capital World Investors | 250,000 | $573.0K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 262,368 | $601.0K | 0.00% | +8,643+3.4% | Added |
| D. E. Shaw & Co., Inc. | 278,327 | $637.0K | 0.00% | +6,778+2.5% | Added |
| BlackRock Inc. | 281,701 | $645.0K | 0.00% | −8,324−2.9% | Reduced |
| Jane Street Group, LLC | 343,894 | $819.0K | 0.00% | −146,336−29.9% | Reduced |
| Capital International Investors | 448,804 | $1.03M | 0.00% | −132,233−22.8% | Reduced |
| Millennium Management LLC | 573,841 | $1.31M | 0.00% | +120,900+26.7% | Added |
| Baillie Gifford & Co | 788,837 | $1.81M | 0.00% | −92,095−10.5% | Reduced |
| Principal Financial Group Inc | 1,343,467 | $3.08M | 0.00% | −4,845−0.4% | Reduced |
| Credit Suisse AG | 1,438,255 | $3.29M | 0.00% | 00.0% | Unchanged |
| Long Focus Capital Management, LLC | 2,683,633 | $6.15M | 1.30% | −107,977−3.9% | Reduced |
| Sofos Investments, Inc. | 8 | – | – | −4−33.3% | Reduced |
| Bpifrance SA | 0 | $0 | 0.00% | −425,726−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −16,366−100.0% | Sold out |
| BNP Paribas Arbitrage, SA | 0 | $0 | 0.00% | −229−100.0% | Sold out |
| Toronto Dominion Bank | 0 | $0 | 0.00% | −31−100.0% | Sold out |